Novel Hydrazide‐Hydrazones Bearing a Benzimidazole Ring: Design, Synthesis, and Evaluation of Inhibitor Properties Against CA I and CA II Isozymes
Chemical Biology & Drug Design · 2024
DOI: 10.1111/cbdd.70025 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemical Biology & Drug Design, 2024. Verfasst von Ayşen Işık und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, Faculty of Science, Selçuk University, Konya, Turkey. Hauptthemen laut MEDLINE: Carbonic Anhydrase Inhibitors, Carbonic Anhydrase II, Hydrazones, Carbonic Anhydrase I. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 58 Literaturangaben. Gefördert von: Selçuk University Research Foundation.
Abstract (Originalsprache)
In this study, we propose identifying potential novel compounds targeting carbonic anhydrase I and II. Herein, we have designed and synthesized new benzimidazole‐hydrazide‐hydrazones derivatives ( 4a‐4r ) to investigate the effects of these synthesized compounds on CA isoenzymes. The compounds' 1 H NMR, 13 C NMR, and HRMS spectra were used to confirm their chemical structures. The synthetic derivatives were screened for their inhibitory potential against carbonic anhydrase I and II by in vitro assay. These compounds have IC 50 values of 3.727–1.493 μM (hCA I) and 3.892–1.547 μM (hCA II). Inhibition types and K i values of the compounds were determined. The K i values of the compounds were 3.006 ± 0.17 μM‐0.356 ± 0.0 μM (hCA I) and 2.923 ± 0.15 μM‐0.346 ± 0.0 μM (hCA II). Acetazolamide (AAZ) was used as the reference in the study. The most potent derivatives, a 4‐methoxy derivative (compound 4k ) and 4‐(trifluoromethyl) derivative (compound 4g ), than AAZ (IC 50 = 2.26 μM) and their IC 50 values were found as 1.493 μM and 1.675 μM, respectively. Compared to AAZ, the other derivatives having more effect on hCA I were compounds 4b , 4e , 4l , 4m , 4n , and 4o . The compounds gave IC 50 values of 1.743, 1.789, 1.933, 1.966, 1.983, and 1.986 μM, respectively. Compounds 4a‐4r found no more effective inhibitory activity against hCA II isozyme than AAZ (IC 50 = 1.17 μM). According to the in vitro test results, detailed protein‐ligand interactions of the compounds 4b and 4k exhibited considerably low binding energies, suggesting strong interaction affinities against hCA I. In addition, the cytotoxic effects of the compounds on the L929 healthy cell line were evaluated.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry, Faculty of Science, Selçuk University, Konya, Turkey.
- Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Anadolu University, Eskişehir, Turkey.
- Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Erciyes University, Kayseri, Turkey.
- Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Selçuk University, Konya, Turkey.
- Department of Food Technology, ErzurumVocational Training School, Ataturk University, Erzurum, Turkey.
- Department of Biochemistry, Faculty of Pharmacy, Cumhuriyet University, Sivas, Turkey.
ORCID-Profile: Ulviye Acar Çevik, Ismail Celik
Förderung
- Selçuk University Research Foundation
Zitieren
APA
Işık, A., Acar Çevik, U., Celik, I., Küçükoğlu, K., Nadaroglu, H., Bostancı, H. E., Özkay, Y., & Kaplancıklı, Z. A. (2024). Novel Hydrazide‐Hydrazones Bearing a Benzimidazole Ring: Design, Synthesis, and Evaluation of Inhibitor Properties Against CA I and CA II Isozymes. Chemical Biology & Drug Design. https://doi.org/10.1111/cbdd.70025
Vancouver
Işık A, Acar Çevik U, Celik I, Küçükoğlu K, Nadaroglu H, Bostancı HE, et al. Novel Hydrazide‐Hydrazones Bearing a Benzimidazole Ring: Design, Synthesis, and Evaluation of Inhibitor Properties Against CA I and CA II Isozymes. Chemical Biology & Drug Design. 2024. doi:10.1111/cbdd.70025
BibTeX
@article{Ik2024,
author = {Işık, Ayşen and Acar Çevik, Ulviye and Celik, Ismail and Küçükoğlu, Kaan and Nadaroglu, Hayrunnisa and Bostancı, Hayrani Eren and Özkay, Yusuf and Kaplancıklı, Zafer Asım},
title = {Novel Hydrazide‐Hydrazones Bearing a Benzimidazole Ring: Design, Synthesis, and Evaluation of Inhibitor Properties Against CA I and CA II Isozymes},
journal = {Chemical Biology & Drug Design},
year = {2024},
doi = {10.1111/cbdd.70025}
}
EUVIMED